Literature DB >> 7928289

Analysis of integrated hepatitis B virus DNA and flanking cellular sequences in the hepatocellular carcinoma cell line HCC36.

J Y Chen1, T J Harrison, D J Tsuei, T Y Hsu, A J Zuckerman, T S Chan, C S Yang.   

Abstract

A hepatocellular carcinoma cell line, HCC36, was established from an adult HBV carrier in Taiwan. From Southern blot analysis, there were at least four sites of integration of HBV DNA, and no viral replicative intermediates were detected. A genomic library was constructed from HCC36 DNA, and two phage clones, designated lambda 36A and lambda 36B, were shown to contain HBV DNA and flanking cellular sequences. In lambda 36A, HBV DNA sequences were quite conserved, and 7.4% base variation was detected. The viral sequences in lambda 36A and lambda 36B differed in only four bases, in addition to the microdeletion and -insertion observed in lambda 36B. The flanking cellular sequences identified in lambda 36A were human Alu sequences and in lambda 36B satellite sequences.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7928289     DOI: 10.1159/000150355

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  2 in total

1.  Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus.

Authors:  Fat-Moon Suk; Min-Hui Lin; Margaret Newman; Shann Pan; Sheng-Hsuan Chen; Jean-Dean Liu; Chiaho Shih
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122.

Authors:  Lan-Ting Yuan; Wei-Jiunn Lee; Yi-Chieh Yang; Bo-Rong Chen; Ching-Yao Yang; Min-Wei Chen; Ji-Qing Chen; Michael Hsiao; Ming-Hsien Chien; Kuo-Tai Hua
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.